BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21213109)

  • 1. Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide.
    Skogastierna C; Luksha L; Kublickiene K; Eliasson E; Rane A; Ekström L
    Heart Vessels; 2011 Nov; 26(6):628-36. PubMed ID: 21213109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
    Aoki C; Nakano A; Tanaka S; Yanagi K; Ohta S; Jojima T; Kasai K; Takekawa H; Hirata K; Hattori Y
    Int J Cardiol; 2012 Apr; 156(1):55-61. PubMed ID: 21093076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression.
    Fisslthaler B; Michaelis UR; Randriamboavonjy V; Busse R; Fleming I
    Biochim Biophys Acta; 2003 Feb; 1619(3):332-9. PubMed ID: 12573493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells.
    Ozaki K; Yamamoto T; Ishibashi T; Matsubara T; Nishio M; Aizawa Y
    Jpn J Pharmacol; 2001 Feb; 85(2):147-54. PubMed ID: 11286396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of microRNA-199 by Nitric Oxide in Endothelial Cells Is Required for Nitrovasodilator Resistance via Targeting of Prostaglandin I2 Synthase.
    Bai YP; Zhang JX; Sun Q; Zhou JP; Luo JM; He LF; Lin XC; Zhu LP; Wu WZ; Wang ZY; Zhang GG
    Circulation; 2018 Jul; 138(4):397-411. PubMed ID: 29431644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism.
    Abe K; Nakayama M; Yoshimura M; Nakamura S; Ito T; Yamamuro M; Sakamoto T; Miyamoto Y; Yoshimasa Y; Saito Y; Nakao K; Yasue H; Ogawa H
    Pharmacogenet Genomics; 2005 May; 15(5):329-36. PubMed ID: 15864134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical promoter region for statin-induced human endothelial nitric oxide synthase (eNOS) transcription in EA.hy926 cells.
    Mashimo Y; Ishikawa T; Numakura M; Kinoshita M; Teramoto T
    J Atheroscler Thromb; 2013; 20(4):321-9. PubMed ID: 23258079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
    Xenos ES; Stevens SL; Freeman MB; Cassada DC; Goldman MH
    Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
    Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of simvastatin on the thromboxane and prostacyclin pathways, in vitro and in vivo.
    Skogastierna C; Björkhem-Bergman L; Bergman P; Eliasson E; Rane A; Ekström L
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):1-7. PubMed ID: 22987053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
    Nishimatsu H; Suzuki E; Satonaka H; Takeda R; Omata M; Fujita T; Nagai R; Kitamura T; Hirata Y
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1770-6. PubMed ID: 15550522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells.
    Pérez-Cremades D; Bueno-Betí C; García-Giménez JL; Ibañez-Cabellos JS; Hermenegildo C; Pallardó FV; Novella S
    J Cell Mol Med; 2017 Aug; 21(8):1584-1592. PubMed ID: 28244682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver.
    Kocarek TA; Reddy AB
    Drug Metab Dispos; 1996 Nov; 24(11):1197-204. PubMed ID: 8937853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an estrogen/statin combination on biochemical markers of endothelial function in human coronary artery cell cultures.
    Mueck AO; Seeger H; Deuringer FU; Wallwiener D
    Menopause; 2001; 8(3):216-21. PubMed ID: 11355045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules.
    Mueck AO; Seeger H; Wallwiener D
    Exp Clin Endocrinol Diabetes; 2001; 109(3):181-3. PubMed ID: 11409302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.
    Murata T; Kinoshita K; Hori M; Kuwahara M; Tsubone H; Karaki H; Ozaki H
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2335-42. PubMed ID: 16166567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells.
    Sekiya A; Morishita E; Maruyama K; Torishima H; Ohtake S
    J Atheroscler Thromb; 2015 Jul; 22(7):660-8. PubMed ID: 25735397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report.
    McLean DL; Kim J; Kang Y; Shi H; Atkins GB; Jain MK; Chun HJ
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2640-3. PubMed ID: 22995518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.